Safety of intracameral mydriasis in phacoemulsification cataract surgery

Journal of Cataract and Refractive Surgery

Volumn 32, Issue 3, 2006, Pages 375-376

  Soong, Terrence ^a   Soultanidis, Marinos ^a   Claoué, Charles ^a   Gallagher, Michael ^a   Thomson, Simon ^a  

^a Salford ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPENTOLATE; LIDOCAINE; MYDRIATIC AGENT; PHENYLEPHRINE; STEROID;

ADHESION; CAPSULORHEXIS; CARDIOTOXICITY; CATARACT; CATARACT EXTRACTION; CLINICAL ARTICLE; COST CONTROL; DRUG SAFETY; HUMAN; HYPERTENSION; IRIDOCYCLITIS; LETTER; MYDRIASIS; OUTPATIENT; PHACOEMULSIFICATION; PILOT STUDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PSEUDOEXFOLIATION; SYSTOLIC BLOOD PRESSURE; VISUAL ACUITY;

ANTERIOR CHAMBER; BLOOD PRESSURE; CYCLOPENTOLATE; DRUG THERAPY, COMBINATION; HEART RATE; HUMANS; INJECTIONS; LENS IMPLANTATION, INTRAOCULAR; LIDOCAINE; MYDRIATICS; PHACOEMULSIFICATION; PHENYLEPHRINE; PILOT PROJECTS; PUPIL;

EID: 33646046442     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2005.12.088     Document Type: Letter

References (5)

1. Lundberg B., and Behndig A. Intracameral mydriatics in phacoemulsification cataract surgery. J Cataract Refract Surg 29 (2003) 2366-2371
2. Fraunfelder F.T., and Scafidi A.F. Possible adverse effects from topical ocular 10% phenylephrine. Am J Ophthalmol 85 (1978) 447-453
3. Fraunfelder F.T., and Meyer S.M. Possible cardiovascular effects secondary to topical ophthalmic 2.5% phenylephrine. [letter]. Am J Ophthalmol 99 (1985) 362-363
4. Hakim O.J., Orton R.B., and Cadera W. Topical 2.5% and 5% phenylephrine:comparison of effects on heart rate and blood pressure. Can J Ophthalmol 25 (1990) 336-339
5. Meyer S.M., and Fraunfelder F.T. Phenylephrine hydrochloride. Ophthalmology 87 (1980) 1177-1180